Company intelligence / Profile preview

Innova Medical Group

Pasadena, California, United States

Ownership: Private
Employees: ~36
Development stage: Other

Overview

Innova Medical Group is a leading developer and manufacturer of rapid diagnostic tests, especially for COVID-19, and has delivered nearly 1.5 billion COVID-19 test kits to England. Its tests have been widely adopted in Europe and used by governments and healthcare providers globally. The company has also expanded into other infectious disease, cancer, and cardiovascular diagnostics. Its lateral flow tests for COVID-19 were critical to the UK's mass testing program.[1][2][6]

Therapeutic areas: CardiovascularOncologyInfectious DiseasesNeurology
Modalities: Device
Industry: Protein Biomarker Diagnostics

Partnerships

iXensor

Beyond the preview

Go deeper on Innova Medical Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innova Medical Group.

Explore the full profile